lung
Merck seeks new Keytruda indication in US
April 20, 2015Sales and Marketing Cancer, FDA, NSCLC, PD-L1, US, keytruda, lung, pembrolizumab
Merck is seeking FDA approval for its successful melanoma drug Keytruda to be used treating lung cancer. The Supplemental Biologics …
Priority review for Pfizer’s lung drug
February 23, 2015Sales and Marketing FDA, Pfizer, Rapamune, lung, lymphangioleiomyomatosis, sirolimus
The US Food and Drug Administration FDA has accepted Pfizer’s lung drug Rapamune for priority review. Rapamune (sirolimus) prevents organ …
FDA fast-tracks Roche lung cancer drug
February 2, 2015Sales and Marketing Cancer, FDA, MPDL3280A, Roche, bladder, lung, oncology, pdl1
Roche will be celebrating after its investigational cancer drug MPDL3280A has been fast-tracked by the FDA for the second time. …
Top four cancer killer rates ‘fall by a third’
August 18, 2014Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research
Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …
InterMune drops EMA lawsuit over data release
June 10, 2014Research and Development, Sales and Marketing EMA, EU, Esbriet, Goldacre, InterMune, alltrials, lung
InterMune has ended a year-long legal spat with the European Medicines Agency over the potential release of data for its …
EMA accepts Boehringer IPF drug
June 6, 2014Sales and Marketing Boehringer, EMA, IPF, inpulsis, lung, nintedanib
Boehringer Ingelheim has moved a step closer to getting its investigational treatment nintedanib approved in Europe for a potentially fatal …
FDA approves Zykadia for late-stage lung cancer
April 30, 2014Research and Development, Sales and Marketing Cancer, FDA, Novartis, lung, zykadia
Novartis’ ‘breakthrough’ drug Zykadia has been approved by the FDA to treat lung cancer patients with a particular genetic mutation. …
Cancer Research funding to be doubled
April 30, 2014Research and Development, Sales and Marketing CRUK, Cancer, brain, breast, funding, lung
Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …
InterMune scores in lung trial
February 26, 2014Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung
InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …
Roche signs $17 million immatics deal
November 15, 2013Research and Development, Sales and Marketing Cancer, Roche, immatics, lung, prostate
Roche is to pay German biotech company immatics $17 million to collaborate on the search for vaccines in various cancers, …
UK government launches lung cancer awareness campaign
May 8, 2012Medical Communications Cancer, UK, government, lung
The UK government has launched a new lung cancer awareness campaign backed by a number of celebrities. Ricky Gervais and …
Latest content
FibroFind appoints Lee Borthwick as CEO
